Dr. Carson Bogatto , MD
Dermatology β’ Houston, TX
2222 N Shepherd Dr Ste 102
Houston, TX 770083165
This profile restates public CMS/NPPES data; T-MedInfo gives no medical advice — consult a licensed professional, and call 911 for emergencies.
-
NPI assigned on April 5, 2022; this date does not establish years in practice.
-
Published CMS data list 67 Medicare Part D prescriptions, including refills, in 2024.
Source: CMS, Medicare Part D Prescribers β by Provider and Drug, 2024. Published rows only; this is not a quality measure.
-
Published Part D records, 2024:
- Ketoconazole β 35 prescription fills, including refills.
- Clobetasol Propionate β 17 prescription fills, including refills.
- Triamcinolone Acetonide β 15 prescription fills, including refills.
Source: CMS, Medicare Part D Prescribers β by Provider and Drug, 2024. Drug names come from pharmacy claims. Listing a drug here is not an endorsement or a recommendation.
See the full table Β· Guide: How to read Medicare Part D prescriber data
-
Fewer Part D prescriptions than 85% of clinicians listed under Dermatology in Houston, TX (2024, 131 clinicians with data). Median for this group: 359. Middle half: 150 to 659.
Fewer Part D prescriptions than 90% of clinicians listed under Dermatology in Texas (2024, 922 clinicians with data). Median for this group: 486. Middle half: 202 to 949.
Source: CMS, Medicare Part D Prescribers β by Provider and Drug, 2024. Billing and prescribing volume is not a quality rating.
Practice Location & Contact Primary Location
2222 N Shepherd Dr Ste 102
Houston, TX 770083165
Medicare Profile & Education
Source: CMS Doctors and Clinicians National Downloadable File
2022
What Public CMS Data Show
Dermatology: NPPES taxonomy is a reported classification, not proof of board certification.
30-day fills
76 standardized 30-day fills in 2024
CMS converts prescriptions to 30-day supplies so they can be compared. A 90-day prescription counts as about three 30-day fills.
What this does not show: 30-day fills
It is not a count of patients and not a measure of quality.
Part D drug cost
$1,472 in 2024
The total cost of these prescriptions in 2024, paid by Medicare drug plans, patients and other payers together.
It shows the total spending on drugs this clinician prescribed, not what any one patient paid.
What this does not show: Part D drug cost
A higher cost often reflects the type of medicines a specialty uses. It is not your out-of-pocket cost and not a measure of quality.
Source: CMS, Medicare Part D Prescribers β by Provider and Drug, 2024.
Open Payments general payments, program year 2025
All general payments: $1,989.09 across 48 records.
By nature of payment
- Food and Beverage: $1,989.09 across 48 records.
Reporting-company totals (3 largest of 15)
- Sanofi and Genzyme US Companies: $354.32 across 9 records.
- UCB, Inc.: $312.36 across 9 records.
- ABBVIE INC.: $309.05 across 9 records.
A reported payment does not necessarily mean the financial relationship is improper and is not a measure of care quality. Clinicians can review and dispute these records.
Source: Calculated by T-MedInfo from CMS Open Payments general-payment records for program year 2025 (published June 30, 2026).
Years since graduation
4 years (graduated 2022)
CMS Doctors and Clinicians data list 2022 as the year this clinician finished professional school.
It tells you roughly how long ago the clinician finished school.
What this does not show: Years since graduation
It is not the number of years in practice, and more years does not mean better care.
Source: CMS Doctors and Clinicians National Downloadable File.
NPI first issued
2022
The year this clinician's National Provider Identifier (NPI) was issued. An NPI is a unique 10-digit ID that US health care providers use for billing.
What this does not show: NPI first issued
NPIs have been issued only since 2005, so this year is not necessarily when the clinician started practicing.
Source: CMS NPPES NPI Registry.
May accept Medicare assignment
CMS data show this clinician may accept Medicare assignment. Clinicians who do not always accept assignment can decide case by case.
Ask the office before your visit. If a clinician does not accept assignment for a service, they can charge up to 15% more than the Medicare-approved amount, and you may be asked to pay the full amount at the visit.
Medicare assignment applies to Original Medicare. It does not tell you whether the clinician is in a Medicare Advantage plan's network, accepts other insurance, or is taking new patients.
Source: CMS Doctors and Clinicians; Medicare.gov, βDoes your provider accept Medicare as full payment?β
No telehealth indicator
CMS shows this indicator only when recent Medicare claims include telehealth services. The clinician may still offer telehealth; ask the office.
Source: CMS, Telehealth Indicator on Medicare Care Compare (fact sheet, January 2023); CMS Doctors and Clinicians.
Enrolled in Medicare (PECOS)
Dr. Bogatto has a Medicare enrollment record in PECOS, the CMS system clinicians use to enroll so they can bill Medicare or order services for people with Medicare.
It does not show whether the clinician accepts assignment, is in your plan's network, or is taking new patients.
Source: CMS Medicare Fee-For-Service Public Provider Enrollment (PECOS); CMS Order and Referring file.
Can order Medicare-covered services
CMS lists Dr. Bogatto as eligible to order or refer Medicare Part B clinical laboratory and imaging services, durable medical equipment (DME) and home health services for people with Medicare.
Medicare pays for these items and services only when they are ordered by an eligible clinician.
What this does not show: Can order Medicare-covered services
It does not mean the clinician offers these services directly.
Source: CMS Medicare Fee-For-Service Public Provider Enrollment (PECOS); CMS Order and Referring file.
Compared with the same specialty in Houston and Texas
Billing and prescribing volume is not a quality rating.
Medicare Part D prescriptions
Fewer Part D prescriptions than 85% of clinicians listed under Dermatology in Houston, TX (2024, 131 clinicians with data). Median for this group: 359. Middle half: 150 to 659.
Fewer Part D prescriptions than 90% of clinicians listed under Dermatology in Texas (2024, 922 clinicians with data). Median for this group: 486. Middle half: 202 to 949.
Part D drug cost
A lower Part D drug cost than 85% of clinicians listed under Dermatology in Houston, TX (2024, 131 clinicians with data). Median for this group: $28,743. Middle half: $3,848 to $161,333.
A lower Part D drug cost than 90% of clinicians listed under Dermatology in Texas (2024, 922 clinicians with data). Median for this group: $81,547. Middle half: $6,986 to $226,319.
168 active clinicians are listed under Dermatology with a practice address in Houston, TX (1,173 in Texas).
Addresses are self-reported to NPPES and may be out of date.
Telehealth indicator in Houston
5.4% of these 168 clinicians have the CMS telehealth indicator.
66.7% of these 168 clinicians are listed by CMS as accepting Medicare assignment.
CMS data by year
Changes may reflect reporting, coverage or privacy limits, not changes in care quality.
-
Medicare Part D prescriptions
CMS data for Part D prescriptions are available for 2024 only.
-
30-day fills
CMS data for 30-day fills are available for 2024 only.
-
Part D drug cost
CMS data for Part D drug cost are available for 2024 only.
-
Industry payments (Open Payments)
Industry payments (Open Payments) went from $22.77 in 2023 to $1,989.09 in 2025.
- 2023: $22.77
- 2024: $1,172.12
- 2025: $1,989.09
Sources: CMS Medicare Part D Prescribers (2024), CMS Open Payments (2025), CMS Doctors and Clinicians, CMS NPPES NPI Registry. Specialty names follow the NUCC Health Care Provider Taxonomy.
Text: T-MedInfo Β· Report an error.
Pharma & Medical Device Financial Disclosures
Payments and other transfers of value that drug and medical device companies reported to CMS Open Payments
Program year 2025 (payments made January 1 β December 31, 2025): 48 records totaling $1,989.09.
| Manufacturer | Payment Nature | Product | Type | Amount ($) |
|---|---|---|---|---|
| Galderma Laboratories, L.P. |
Food and Beverage
In-kind items and services
|
NEMLUVIO | General | $150.00 |
| UCB, Inc. |
Food and Beverage
In-kind items and services
|
Bimzelx | General | $148.75 |
| Janssen Pharmaceuticals, Inc |
Food and Beverage
In-kind items and services
|
TREMFYA | General | $130.53 |
| ABBVIE INC. |
Food and Beverage
In-kind items and services
|
RINVOQ | General | $125.00 |
| Boehringer Ingelheim Pharmaceuticals, Inc. |
Food and Beverage
In-kind items and services
|
SPEVIGO | General | $125.00 |
| Sanofi and Genzyme US Companies |
Food and Beverage
In-kind items and services
|
DUPIXENT | General | $118.55 |
| Botanix SB Inc |
Food and Beverage
In-kind items and services
|
SOFDRA | General | $102.00 |
| Krystal Biotech Inc |
Food and Beverage
In-kind items and services
|
VYJUVEK | General | $100.14 |
| UCB, Inc. |
Food and Beverage
In-kind items and services
|
Bimzelx | General | $40.45 |
| Sanofi and Genzyme US Companies |
Food and Beverage
In-kind items and services
|
DUPIXENT | General | $38.31 |
| Sanofi and Genzyme US Companies |
Food and Beverage
In-kind items and services
|
β | General | $37.86 |
| UCB, Inc. |
Food and Beverage
In-kind items and services
|
Bimzelx | General | $36.25 |
| UCB, Inc. |
Food and Beverage
In-kind items and services
|
Bimzelx | General | $35.33 |
| Regeneron Pharmaceuticals, Inc. |
Food and Beverage
In-kind items and services
|
LIBTAYO | General | $33.76 |
| Boehringer Ingelheim Pharmaceuticals, Inc. |
Food and Beverage
In-kind items and services
|
SPEVIGO | General | $32.58 |
| Sanofi and Genzyme US Companies |
Food and Beverage
In-kind items and services
|
β | General | $32.35 |
| UCB, Inc. |
Food and Beverage
In-kind items and services
|
Bimzelx | General | $30.58 |
| LEO Pharma Inc. |
Food and Beverage
In-kind items and services
|
ANZUPGO | General | $29.59 |
| ABBVIE INC. |
Food and Beverage
In-kind items and services
|
RINVOQ | General | $29.45 |
| ABBVIE INC. |
Food and Beverage
In-kind items and services
|
SKYRIZI | General | $29.33 |
| Regeneron Pharmaceuticals, Inc. |
Food and Beverage
In-kind items and services
|
DUPIXENT | General | $29.28 |
| Sanofi and Genzyme US Companies |
Food and Beverage
In-kind items and services
|
DUPIXENT | General | $29.08 |
| Novartis Pharmaceuticals Corporation |
Food and Beverage
In-kind items and services
|
COSENTYX | General | $29.08 |
| ABBVIE INC. |
Food and Beverage
In-kind items and services
|
SKYRIZI | General | $28.18 |
| Regeneron Pharmaceuticals, Inc. |
Food and Beverage
In-kind items and services
|
DUPIXENT | General | $28.03 |
(top 25 shown)
Source: CMS Open Payments, program year 2025, released June 30, 2026.
Medicare Part D Prescribing Profile & Medications
Medicare Part D prescriptions filled, including refills, in 2024.
| Brand Name | Generic Name | Prescriptions | Day Supply | Total Cost | Patients |
|---|---|---|---|---|---|
| Ketoconazole | Ketoconazole | 35 | 872 | $697.77 | 19 |
| Clobetasol Propionate | Clobetasol Propionate | 17 | 413 | $560.69 | 14 |
| Triamcinolone Acetonide | Triamcinolone Acetonide | 15 | 684 | $213.88 | 11 |
Source: CMS Part D by Provider and Drug, 2024; rows below 11 claims omitted by CMS; volume isn’t quality. Privacy limits
Specialties & License Numbers Reported to NPPES
Self-certified to NPPES: 2026-03-03NUCC Taxonomy Code: 207N00000X
A dermatologist is trained to diagnose and treat pediatric and adult patients with benign and malignant disorders of the skin, mouth, external genitalia, hair and nails, as well as a number of sexually transmitted diseases. The dermatologist has had additional training and experience in the diagnosis and treatment of skin cancers, melanomas, moles and other tumors of the skin, the management of contact dermatitis and other allergic and nonallergic skin disorders, and in the recognition of the skin manifestations of systemic (including internal malignancy) and infectious diseases. Dermatologists have special training in dermatopathology and in the surgical techniques used in dermatology. They also have expertise in the management of cosmetic disorders of the skin such as hair loss and scars and the skin changes associated with aging.
Medicare (PECOS) Enrollment & Ordering Eligibility
Source: CMS PECOSPRACTITIONER - DERMATOLOGY
I20260310002185
TX
4981084571
Sources: CMS Provider Enrollment and Order and Referring. Medicare enrollment is a billing status, not an accreditation or quality rating.
Career & Practice History Timeline
Changes recorded in monthly NPPES data files: addresses, names, credentials, specialties and NPI status
Registered at 2222 N SHEPHERD DR STE 102, HOUSTON, TX 770083165 (Tel: 2815015624)
Registered at 2222 N SHEPHERD DR STE 102, HOUSTON, TX 770083165 (Tel: 2815015624)
Recorded as CARSON BOGATTO, MD
Dermatology (license number reported to NPPES: TX W3770)
Registered at 2000 CANAL ST, NEW ORLEANS, LA 701123018 (Tel: 5045687110)
Registered at 2021 PERDIDO ST STE 7153, NEW ORLEANS, LA 701121352 (Tel: 5045687110)
NPI status registered as active in NPPES database
Registered at 1430 TULANE AVE # 8050, NEW ORLEANS, LA 701122632 (Tel: 5049887809)
Registered at 1430 TULANE AVE # 8050, NEW ORLEANS, LA 701122632 (Tel: 5049887809)
Recorded as CARSON BOGATTO
Student in an Organized Health Care Education/Training Program
First registered as active Individual Practitioner in NPPES Database.
NPI Administrative Meta
Other Dermatology Specialists in Houston
- Dr. Karrie Amor, MD
- Dr. Betty Markham, MD
- Dr. Vartan Pahalyants, MD, MBA
- Dr. Tracy Katz, MD
- Dr. Taylor Duke, MD
- Alpesh Desai
Mailing Address
2222 N Shepherd Dr Ste 102
Houston, TX 770083165
Phone: 2815015624